Ranbaxy-Ace Pharma Company

Only available on StudyMode
  • Download(s) : 101
  • Published : March 5, 2011
Open Document
Text Preview
Management Trainee Programme

Agenda

• •
What we do…
– About Ranbaxy Group

How we do it…
– Ranbaxy Advantage

How you fit in...
– The Management Trainee Program

What we do……

An Overview
• Among India’s largest pharmaceutical companies • Ranbaxy & Daiichi Sankyo combined rank among the top 20 global pharmaceutical companies • Worldwide Presence

• Ground presence in 46 countries, products sold in over 125 countries • Manufacturing locations in 7 countries • Global consolidated sales – US $ 1519 Mn (2009)

• Highest R&D spender amongst Indian Pharmaceutical companies • Business - International 77%

- Domestic

23%

• Around 14000 employees globally represented by 50 nationalities

Where we operate

Ranbaxy – Daiichi Sankyo Partnership
• • A path breaking confluence that redefines the global pharma paradigm Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse

Global Pharma Innovator


Global Generics Company
Significant and sustained operational and strategic synergies across the globe – Collaborative marketing opportunities leveraging Ranbaxy’s substantial footprint – Manufacturing – R&D – Global supply chain – IT functions Combining innovator and generics capabilities, to straddle full spectrum of pharma value chain

Hybrid
Business Model


Ranbaxy Corporate Office

Our state-of-the-art Head Quarters is located at Gurgaon, New Delhi NCR The ‘Brain Center’ for all our Global Strategies

Vision, Mission & Values
Mission
• To become a Research-based International Pharmaceutical Company”

Vision 2012 • Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets

Values • • • Achieving customer satisfaction is fundamental to our business Provide products and services of the highest quality Practice dignity and equity in relationships and provide opportunities for our people to realise their full potential • • • • Ensure profitable growth and enhance wealth of the shareholders Foster mutually beneficial relations with all our business partners Manage our operations with high concern for safety and environment Be a responsible corporate citizen

Research & Development
• Dedicated Facilities for Innovative & Generics Research
• More than 1200 R&D Personnel

• Highest R&D spender amongst Indian Pharmaceutical companies

• NDDS based products (4 platform technologies)
• NDDR - Arterolane + PQP (Anti malaria) • One program with GSK (Respiratory) Collaboration in Clinical Development of NCE

• R&D collaborations with Industry & Academia

Research & Development
State-of-the-art R&D facilities based in Gurgaon (India)

R&D I

R&D II

R&D III

R&D IV

R&D V

R&D VI

Global Manufacturing Strengths
• cGMP compliant world-class API & Dosage Forms manufacturing facilities across the globe • 7 manufacturing locations worldwide • API facilities - increasing vertical integration • Creating capacities for specialty products

• New facilities added in cost advantageous geographies

Global Manufacturing Strengths

USA

Ireland

Romania

Nigeria

India

South Africa

Malaysia

Key Strengths
• Our innovative use of technology • Knowledge of our markets • Empowerment & Independency • The aptitude of our people

• Confidence in our expertise • Our ability to react swiftly • Calculated risk taking ability

Ranbaxy is the partner of choice

Global Sales Split
CIS*

86 Mn 6%
North America

Asia

441 Mn 29%

397 Mn 26%

214 Mn 14%
RoW

269 Mn 18%
Europe

112 Mn 7%
API

All figures in US $

US $ 1519 Mn (2009)
* CIS includes Russia & Ukraine belt

How we do it ...

Global Pharmaceutical Landscape
Global Pharma Market Slice US $ Bn
Global Pharmaceuticals Market: • 2009: ~ US $ 727 Bn (+5.7%)

80 152

33
316

Global Generics Market: • 2009: US $ 83 Bn (+7.7%)

Key Drivers of Generics: 226
Significant...
tracking img